Developer docs
API playgroundTry for free, no card

Search company profiles

GENEWEL

Full company profile

uuid000m6ay

Namestring
GENEWEL
Legal namestring
Genewel
Websiteurl
genewel.com
Company typeenum
Private
Founded yearint
2000
Descriptiontext

GENEWEL (제네웰) is a South Korean biomaterial and life science company founded on July 21, 2000, headquartered in Seongnam with a manufacturing facility in Hwaseong. It operates as a consolidated subsidiary of the Dongsung Group conglomerate. The company develops and manufactures medical devices — primarily wound care dressings under the Medifoam® line (foam, hydrocolloid, liquid, scargel), the Healoderm® wound healing product, and the Guardix®/Guardcel® post-surgical anti-adhesion product family — alongside a secondary line of cosmetics ingredient materials including hyaluronic acid freeze-drying substrates, melting films, and the FOAM CULE foam mask fabric. GENEWEL holds registered trademarks across roughly twelve branded product lines in these categories.

The company's revenue model is straightforward B2B product sales: medical devices are sold directly to healthcare providers (hospitals and clinics) and through the Dongsung Group distribution network, while cosmetics materials are sold as inputs to cosmetics manufacturers. Pricing is not publicly disclosed and the business operates without subscription, licensing, or platform economics. Its FY2024 financial statements show ₩35,766M in revenue (approximately USD 27M), ₩9,284M operating profit (~26% operating margin), and ₩7,978M net profit (~22% net margin), with a balance sheet of ₩50,388M in total assets and low leverage (₩7,108M total liabilities). FY2024 revenue grew approximately 10% year-over-year off a flat FY2022–FY2023 base.

GENEWEL's operating footprint is concentrated in South Korea, with stated corporate ambition to evolve into a "global life science company" but no disclosed international revenue, regulatory clearances abroad, or named export channels. The CEO is Sang-Deok Han (한상덕). The company maintains a multilingual corporate website (Korean, English, Chinese) and has not pursued public listing, external venture funding, or M&A activity within the available data.

Short descriptiontext

GENEWEL is a South Korean biomaterial manufacturer and Dongsung Group subsidiary that produces wound care dressings (Medifoam®), post-surgical anti-adhesion products (Guardix®), and hyaluronic acid-based cosmetics materials for healthcare providers and cosmetics OEMs in Korea.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSeongnam, South Korea
HQ citystring
Seongnam
HQ countrystring
South Korea
HQ regionstring
Asia
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
wound care dressings, anti-adhesion products, biomaterial medical devices, hyaluronic acid materials, cosmetic ingredients
Industry3 codes
PRIMARYIMAMAGAF
Medical & Healthcare Hygiene Disposables (Patient Wipes, Underpads)
SECONDARYIMAOADAD
Medical & Hygiene Technical Textiles (Gauze/Drapes/Wipes/Barrier Fabrics)
SECONDARYHLAGABAH
Sterile Fill-Finish & Aseptic Manufacturing CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
NAICS code1 code
  • Medical Equipment and Supplies Manufacturing33911
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Medical Devices
Social media profiles1 record
Revenue model2 records
1Medical Device Sales
TypeHardware Sales
Description

Sales of biomaterial-based medical devices including wound dressings (foam, hydrocolloid, liquid), anti-adhesion products, and other medical supplies primarily to healthcare providers

genewel.com:443
2Cosmetics Materials Sales
TypeOne Time License
Description

Sales of cosmetics ingredient materials including hyaluronic acid freeze-drying materials, melting films, and foam fabric to consumer product manufacturers

genewel.com:443
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

GENEWEL manufactures and sells biomaterial-based medical devices — primarily wound dressings (foam, hydrocolloid, liquid, scargel) and post-surgical anti-adhesion products — along with hyaluronic acid-based cosmetic ingredient materials (freeze-dried materials, melting films, foam mask fabrics) supplied to healthcare providers and cosmetics manufacturers. The company operates a manufacturing facility in Hwaseong and a headquarters in Seongnam, South Korea, and is a subsidiary of the Dongsung Group.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

GENEWEL is a Korean life science company specializing in biomaterials, offering two main product categories: healthcare/biomaterial medical devices and consumer cosmetics materials. The medical device portfolio includes wound care products under brands such as Medifoam® (foam, hydrocolloid, liquid, and scargel dressings), Healoderm®, Guardix®, Guardcel®, Regencol®, Matigen®, Welstop®, Welpass®, Aniguard®, Petera Bandage®, Bariex®, and Barivell®, among others. The consumer/cosmetics segment provides hyaluronic acid-based materials including freeze-drying materials, melting films, mask pack fabrics (FOAM CULE), and HealMyze® products. The company positions these offerings under a unified life science solution umbrella, with wound dressings and anti-adhesives as major product lines.

Product and service1 record
1Medifoam® Foam Dressing
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
1Dongsung Chemical
Strategic tierCoreTypeOthers
Description

Parent company and primary affiliated entity within the Dongsung Group. Genewel operates as a subsidiary with shared resources, distribution networks, and group-wide marketing initiatives. The company is part of the Dongsung Group family of companies.

genewel.com:443
Strategic tierMinorTypeOthers
Description

Affiliated company within the Dongsung Group network. Operates under the same corporate umbrella with shared brand presence and cross-marketing opportunities through group websites.

3HealMize
Strategic tierMinorTypeOthers
Description

Affiliated consumer health brand within the Dongsung Group. Listed as a family site company with joint brand presence and potential cross-marketing synergies in the consumer health and cosmetics segments.

genewel.com:443
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers8 records
TypeDirect peer
Description

Global advanced wound care leader with foam, hydrocolloid, and antimicrobial dressings (e.g., AQUACEL, Foam Lite) that compete directly with GENEWEL's Medifoam® portfolio in hospitals and post-acute care.

TypeDirect peer
Description

Premium wound care and surgical solutions company anchored by Mepilex foam dressings and single-use surgical products, directly comparable to GENEWEL's Medifoam® dressings and Guardix® anti-adhesion franchise.

TypeBroad incumbent
Description

Large diversified medical devices company with a strong Advanced Wound Management portfolio (Allevyn, PICO) overlapping with GENEWEL's foam and hydrocolloid dressing categories.

TypeBroad incumbent
Description

Danish wound and skin care specialist with Biatain foam and hydrocolloid dressings, operating in the same advanced wound care category as GENEWEL with strong hospital channel presence.

TypeDirect peer
Description

Holds the Seprafilm anti-adhesion franchise, the most direct global incumbent comparable to GENEWEL's Guardix® post-surgical adhesion prevention product in surgical settings.

TypeDirect peer
Description

Privately held medical products company specializing in wound care, ostomy, and continence care, with overlapping foam and advanced dressing SKUs targeting the same hospital and post-acute customer base.

TypeBroad incumbent
Description

Broad medical products business with Tegaderm foam and hydrocolloid dressings as well as skin and wound care lines that overlap with GENEWEL's hospital-channel wound care portfolio.

TypeRegional player
Description

Leading Korean pharmaceutical and medical device company with adjacent wound care, dermatology, and biomaterial products; competes with GENEWEL in the same domestic Korean hospital and consumer channels.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

GENEWEL

Medical Devicesgenewel.com

GENEWEL is a South Korean biomaterial manufacturer and Dongsung Group subsidiary that produces wound care dressings (Medifoam®), post-surgical anti-adhesion products (Guardix®), and hyaluronic acid-based cosmetics materials for healthcare providers and cosmetics OEMs in Korea.

What GENEWEL does

GENEWEL (제네웰) is a South Korean biomaterial and life science company founded on July 21, 2000, headquartered in Seongnam with a manufacturing facility in Hwaseong. It operates as a consolidated subsidiary of the Dongsung Group conglomerate. The company develops and manufactures medical devices — primarily wound care dressings under the Medifoam® line (foam, hydrocolloid, liquid, scargel), the Healoderm® wound healing product, and the Guardix®/Guardcel® post-surgical anti-adhesion product family — alongside a secondary line of cosmetics ingredient materials including hyaluronic acid freeze-drying substrates, melting films, and the FOAM CULE foam mask fabric. GENEWEL holds registered trademarks across roughly twelve branded product lines in these categories.

The company's revenue model is straightforward B2B product sales: medical devices are sold directly to healthcare providers (hospitals and clinics) and through the Dongsung Group distribution network, while cosmetics materials are sold as inputs to cosmetics manufacturers. Pricing is not publicly disclosed and the business operates without subscription, licensing, or platform economics. Its FY2024 financial statements show ₩35,766M in revenue (approximately USD 27M), ₩9,284M operating profit (~26% operating margin), and ₩7,978M net profit (~22% net margin), with a balance sheet of ₩50,388M in total assets and low leverage (₩7,108M total liabilities). FY2024 revenue grew approximately 10% year-over-year off a flat FY2022–FY2023 base.

GENEWEL's operating footprint is concentrated in South Korea, with stated corporate ambition to evolve into a "global life science company" but no disclosed international revenue, regulatory clearances abroad, or named export channels. The CEO is Sang-Deok Han (한상덕). The company maintains a multilingual corporate website (Korean, English, Chinese) and has not pursued public listing, external venture funding, or M&A activity within the available data.

GENEWEL firmographics

Firmographics
Name
GENEWEL
Legal name
Genewel
Website
https://genewel.com
Company type
Private
Founded year
2000
Operating status
Operating
Headcount range
11–50 employees
Short description
GENEWEL is a South Korean biomaterial manufacturer and Dongsung Group subsidiary that produces wound care dressings (Medifoam®), post-surgical anti-adhesion products (Guardix®), and hyaluronic acid-based cosmetics materials for healthcare providers and cosmetics OEMs in Korea.
Ownership category
akta.pro rank

GENEWEL industry classification

Industry
Product category
Medical Devices
NAICS
Medical Equipment and Supplies Manufacturing (33911)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYIMAMAGAF
Medical & Healthcare Hygiene Disposables (Patient Wipes, Underpads)
SECONDARYIMAOADAD
Medical & Hygiene Technical Textiles (Gauze/Drapes/Wipes/Barrier Fabrics)
SECONDARYHLAGABAH
Sterile Fill-Finish & Aseptic Manufacturing CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)

Keywords

  • Wound care dressings
  • Anti-adhesion products
  • Biomaterial medical devices
  • Hyaluronic acid materials
  • Cosmetic ingredients

Where GENEWEL is headquartered

Location

Headquarters

HQ city
Seongnam
HQ country
South Korea
HQ region
Asia

Offices2 records

Markets served

GENEWEL business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Medical Device Sales: Sales of biomaterial-based medical devices including wound dressings (foam, hydrocolloid, liquid), anti-adhesion products, and other medical supplies primarily to healthcare providers
  2. Cosmetics Materials Sales: Sales of cosmetics ingredient materials including hyaluronic acid freeze-drying materials, melting films, and foam fabric to consumer product manufacturers

Distribution channels3 records

Marketing channels3 records

GENEWEL product offering

Product offering

Core offering

GENEWEL manufactures and sells biomaterial-based medical devices — primarily wound dressings (foam, hydrocolloid, liquid, scargel) and post-surgical anti-adhesion products — along with hyaluronic acid-based cosmetic ingredient materials (freeze-dried materials, melting films, foam mask fabrics) supplied to healthcare providers and cosmetics manufacturers. The company operates a manufacturing facility in Hwaseong and a headquarters in Seongnam, South Korea, and is a subsidiary of the Dongsung Group.

Product overview

GENEWEL is a Korean life science company specializing in biomaterials, offering two main product categories: healthcare/biomaterial medical devices and consumer cosmetics materials. The medical device portfolio includes wound care products under brands such as Medifoam® (foam, hydrocolloid, liquid, and scargel dressings), Healoderm®, Guardix®, Guardcel®, Regencol®, Matigen®, Welstop®, Welpass®, Aniguard®, Petera Bandage®, Bariex®, and Barivell®, among others. The consumer/cosmetics segment provides hyaluronic acid-based materials including freeze-drying materials, melting films, mask pack fabrics (FOAM CULE), and HealMyze® products. The company positions these offerings under a unified life science solution umbrella, with wound dressings and anti-adhesives as major product lines.

Differentiator

Problem solved

Functional benefit

Products and services

  • Medifoam® Foam Dressing

Companies that use GENEWEL

Customer profile

Segments2 records

Ideal customer profiles2 records

GENEWEL technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

GENEWEL partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and minor.

  • Dongsung ChemicalcoreOthersParent company and primary affiliated entity within the Dongsung Group. Genewel operates as a subsidiary with shared resources, distribution networks, and group-wide marketing initiatives. The company is part of the Dongsung Group family of companies.
  • Dongsung FinetecminorOthersAffiliated company within the Dongsung Group network. Operates under the same corporate umbrella with shared brand presence and cross-marketing opportunities through group websites.
  • HealMizeminorOthersAffiliated consumer health brand within the Dongsung Group. Listed as a family site company with joint brand presence and potential cross-marketing synergies in the consumer health and cosmetics segments.

Scale indicators5 records

Recent moves6 records

Expansion highlights4 records

GENEWEL competitors and assessment

Company assessment

Direct peers

  • ConvaTec: Global advanced wound care leader with foam, hydrocolloid, and antimicrobial dressings (e.g., AQUACEL, Foam Lite) that compete directly with GENEWEL's Medifoam® portfolio in hospitals and post-acute care.
  • Mölnlycke Health Care: Premium wound care and surgical solutions company anchored by Mepilex foam dressings and single-use surgical products, directly comparable to GENEWEL's Medifoam® dressings and Guardix® anti-adhesion franchise.
  • Baxter International: Holds the Seprafilm anti-adhesion franchise, the most direct global incumbent comparable to GENEWEL's Guardix® post-surgical adhesion prevention product in surgical settings.
  • Hollister Incorporated: Privately held medical products company specializing in wound care, ostomy, and continence care, with overlapping foam and advanced dressing SKUs targeting the same hospital and post-acute customer base.

Broad incumbents

  • Smith & Nephew: Large diversified medical devices company with a strong Advanced Wound Management portfolio (Allevyn, PICO) overlapping with GENEWEL's foam and hydrocolloid dressing categories.
  • Coloplast: Danish wound and skin care specialist with Biatain foam and hydrocolloid dressings, operating in the same advanced wound care category as GENEWEL with strong hospital channel presence.
  • 3M Health Care: Broad medical products business with Tegaderm foam and hydrocolloid dressings as well as skin and wound care lines that overlap with GENEWEL's hospital-channel wound care portfolio.

Regional players

  • Daewoong Pharmaceutical: Leading Korean pharmaceutical and medical device company with adjacent wound care, dermatology, and biomaterial products; competes with GENEWEL in the same domestic Korean hospital and consumer channels.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

GENEWEL social profiles

Digital presence

GENEWEL financial estimates

Financial estimate

Revenue estimate

Valuation estimate

GENEWEL leadership team

Management profile

Number of profiles

Profiles1 record

GENEWEL funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

GENEWEL M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about GENEWEL

What does GENEWEL do?

GENEWEL manufactures and sells biomaterial-based medical devices — primarily wound dressings (foam, hydrocolloid, liquid, scargel) and post-surgical anti-adhesion products — along with hyaluronic acid-based cosmetic ingredient materials (freeze-dried materials, melting films, foam mask fabrics) supplied to healthcare providers and cosmetics manufacturers. The company operates a manufacturing facility in Hwaseong and a headquarters in Seongnam, South Korea, and is a subsidiary of the Dongsung Group.

Is GENEWEL a public or private company?

GENEWEL is a private company. It is classified as corporate owned and is currently operating.

When was GENEWEL founded?

GENEWEL was founded in 2000. It employs 11 to 50 people.

Where is GENEWEL based?

GENEWEL is headquartered in Seongnam, South Korea, in the Asia region.

How does GENEWEL make money?

Two revenue lines are on record. Medical Device Sales are the primary driver. The others are cosmetics Materials Sales.

Who are GENEWEL's main competitors?

Direct peers on record are ConvaTec, Mölnlycke Health Care, Baxter International and Hollister Incorporated. Broad incumbents are Smith & Nephew, Coloplast and 3M Health Care. Daewoong Pharmaceutical is listed as a regional player.

Does GENEWEL have an API?

No public API is recorded for GENEWEL.

What industry is GENEWEL in?

GENEWEL's product category is Medical Devices. Its primary akta.pro industry code is IMAMAGAF, Medical & Healthcare Hygiene Disposables (Patient Wipes, Underpads), with a secondary code of IMAOADAD, Medical & Hygiene Technical Textiles (Gauze/Drapes/Wipes/Barrier Fabrics). Its NAICS code is 33911 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales